Insider Brief
- Channel Robotics has raised $2.5 million in Seed+ funding, bringing its total funding to $4.6 million, to advance development of a handheld robotic platform for endoscopic procedures.
- The San Diego-based company is developing an AI-enabled system designed to work with existing flexible endoscopes, with the goal of providing robotic-assisted dexterity without the large, capital-intensive robotic platforms commonly used in hospitals.
- Channel Robotics said the funding will support product development, engineering expansion and regulatory preparation ahead of a planned FDA submission in 2027, while also advancing manufacturing and commercialization efforts.
Channel Robotics has raised $2.5 million in Seed+ funding as the medical robotics startup works to commercialize a handheld robotic platform designed to bring advanced robotic capabilities to endoscopic procedures.
The round was led by True Ventures and brings the company’s total funding to $4.6 million, according to the company. Previous seed round investors include Defined Ventures and Old Line Capital Partners.
Based in San Diego, Channel Robotics is developing a handheld, AI-enabled endoscopic robotic system that is designed to work with existing flexible endoscopes. The company says the approach could provide physicians with robotic-assisted dexterity without requiring the large, expensive robotic systems commonly used in hospitals today.
The new funding will support continued product development, expansion of engineering efforts and preparation for regulatory review. Channel Robotics is targeting a U.S. Food and Drug Administration submission in 2027. The company also plans to use the capital to advance manufacturing and quality systems as it prepares for commercialization following regulatory clearance.
“Our mission is to democratize access to advanced endoscopic robotics,” said Michael Yip, PhD, co-founder of Channel Robotics. “This financing enables us to continue building a platform that can bring sophisticated robotic capabilities to physicians in a practical, scalable, and cost-effective way.”
The company said its goal is to expand access to robotic-assisted endoscopic procedures across a broader range of healthcare settings, including hospitals, ambulatory surgery centers and community medical practices.
